Association of trimodality therapy (TMT) with rate of local-regional relapse and rare luminal-only relapse for patients with esophageal and esophagogastric junction (E-EGJ) cancer: Implications for the surveillance strategy
10.1111/apt.12147 99
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
The assay involved the sequential addition of 2 mM malate, 5 mM glutamate, and 10 mM pyruvate (complex I leak respiration), 5 mM ADP (complex I oxidative phosphorylation), 10 mM succinate (complex I + II oxidative phosphorylation), 2.5 M oligomycin (complex I + II leak respiration), 0.5 M FCCP (maximal respiration), and 2.5 M antimycin A (non-mitochondrial respiration)
On September 5, 2025, the U.S
Eden figures verified at checkout, July 2026